Ferriss JS, Kim Y, Theodorescu D, Duska LR, Lee J. A gene expression algorithm for the prediction of platinum sensitivity in ovarian cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.5021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Song S, Lee Y, Kim Y, Yoon S, Lee S, Ahn S, Kim J, Lee D, Lee J, Choi E. Hypofractionated three-dimensional conformal radiotherapy alone in locally advanced, non-small cell lung cancer medically unfit to multimodality treatment. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e17527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Hsu C, Lin C, Cheng JC, Yen C, Lee J, Wang H, Yeh K, Cheng A, Lee Y. Concurrent chemoradiotherapy with cetuximab plus twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.4106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Ryoo B, Yoon D, Ryu M, Lee S, Hwang S, Suh D, Lee J, Kim T, Chang H, Kang Y. Sorafenib for recurrent hepatocellular carcinoma after liver transplantation. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e14669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Jeong J, Sung J, Pyo H, Cho K, Kim H, Han J, Yun T, Lee G, Lee J. Retrospective study of irinotecan plus cisplatin induction followed by concurrent thoracic irradiation with irinotecan plus cisplatin chemotherapy for limited-disease small cell lung cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Lee S, Park Y, Sun J, Seo J, Lee J, Nam S, Yang J, Ahn J, Im Y. Individualized surveillance and follow-up based on breast cancer (BC) subtypes and risk of relapse in BC patients who received curative surgery. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e11053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Park Y, Lee S, Kong J, Cho E, Choi Y, Lee J, Nam S, Yang J, Ahn J, Im Y. Clinical relevance of TNM staging system according to breast cancer (BC) subtypes. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Ryu M, Yoon D, Ryoo B, Beck M, Choi D, Cho Y, Lee J, Chang H, Kim T, Kang Y. Sunitinib as the second-line therapy for advanced GISTs after failure of imatinib in Korean patients. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.10083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Han J, Yoon K, Lee Y, Lee G, Yoon S, Hwang K, Yun T, Kim H, Lee J. DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma (NSLA). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Millenson MM, Lee J, Hanna NH, Langer CJ, Hoang T, Graham DL, Okuno SH, Schiller JH. Pemetrexed (Pem) plus gemcitabine (Gem) or carboplatin (Carbo) in patients (pts) with advanced malignant mesothelioma (MPM): A randomized phase II trial, E1B03. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e18053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Kim S, Yoon D, Cho Y, Nam S, Choi S, Lee S, Lee J, Kim J, Cho K. Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving induction chemotherapy and definitive chemoradiotherapy. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.5524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Tsao AS, Wistuba II, Mehran RJ, Gil J, Nunez M, Lee J, Lin H, Lippman SM, Hong WK. Evaluation of Src Tyr419 as a predictive biomarker in a neoadjuvant trial using dasatinib in resectable malignant pleural mesothelioma. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7042] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Kim J, Yun J, Kong J, Lee S, Kim S, Lee J, Ahn J, Park K, Ahn M. Correlation of genetic polymorphisms in folate metabolic pathway genes with clinical outcomes in pemetrexed-treated advanced NSCLC patients. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Lee H, Lee K, Ahn M, Hwang H, Lee J, Park K, Kim T, Yi C, Chung M. Proposal of new CT response criteria in non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Hamann HA, Lee J, Schiller JH, Horn L, Cleeland CS, Manola J, Wagner LI, Chang VT, Fisch M. Clinician perceptions of care difficulty and quality of life for lung cancer patients: Results from the ECOG SOAPP study (E2Z02). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.9102] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Tevaarwerk A, Lee J, Sesto MC, Buhr KA, Cleeland CS, Manola J, Wagner LI, Chang VT, Fisch M. Predictors of employment (empl) outcomes in outpatients (pts) with common solid tumors: A secondary analysis from E2Z02 (ECOG's SOAPP study). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.9118] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Gold KA, Kim ES, Lee J, Behrens C, Solis L, Liu D, Yuan P, Casey BD, Wistuba II, Hong WK. Biologic risk model development for recurrent and second primary tumors (SPTs) in patients (pts) with early stage non-small cell lung cancer (ES NSCLC). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e17503] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Kim H, Ahn J, Lee H, Kim TM, Lee J, Park K, Sym S, Choi Y, Lee K, Rha SY. Experience of the use of trabectedin (ET-743) in patients with advanced soft tissue sarcoma failing doxorubicin and/or ifosfamide in Korea. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e20518] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Jain RK, Lee J, Ng CS, Hong DS, Gong J, Naing A, Wheler J, Kurzrock R. Survival outcomes of patients who develop new lesions while participating on phase I oncology studies. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e13076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Sun J, Ahn J, Lee J, Park Y, Lee S, Ahn M, Park K. Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e18062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Worden FP, Wolf GT, Lee J, Bradford CR, Chepeha DB, Prince M, Eisbruch A, Moyer J, Urba S, Carey T. Outcomes related to biomarkers in organ preservation for patients with advanced squamous cell carcinoma of the oral cavity (SCCOC). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e16009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Ahn H, Um J, Lee J, Kim W, Lim D, Park J. Analysis of prognostic factors of pediatric-type sarcomas in adult patients. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.10094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Kim S, Lee J, Sun J, Park K, Ahn M, Park Y, Ahn J. Prognostic model to predict outcomes in non-small cell lung cancer patients with erlotinib as salvage treatment. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e18125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Park S, Lee S, Kang J, Hwang I, Lee J, Park J, Park Y, Lim H, Kang W. A feasibility analysis from the patient preference randomized phase III clinical trial of second-line chemotherapy (SLC) in advanced gastric cancer (AGC) patients pretreated with both fluoropyrimidines and platinum. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.4147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Saintigny P, Zhang L, El-Naggar AK, Papadimitrakopoulou V, Feng L, Lee J, Kim ES, Hong WK, Lippman SM, Mao L. Gene expression profiling of oral preneoplastic lesions (OPL) from a prospective prevention trial. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.5521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open